ATE553116T1 - Metall bindende verbindungen und ihre verwendungen - Google Patents

Metall bindende verbindungen und ihre verwendungen

Info

Publication number
ATE553116T1
ATE553116T1 AT00967163T AT00967163T ATE553116T1 AT E553116 T1 ATE553116 T1 AT E553116T1 AT 00967163 T AT00967163 T AT 00967163T AT 00967163 T AT00967163 T AT 00967163T AT E553116 T1 ATE553116 T1 AT E553116T1
Authority
AT
Austria
Prior art keywords
metal
animal
reducing
binding compound
provides
Prior art date
Application number
AT00967163T
Other languages
English (en)
Inventor
David Bar-Or
C Gerald Curtis
Edward Lau
Nagaraja K R Rao
James V Winkler
Wannell M Crook
Original Assignee
Dmi Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26854102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE553116(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dmi Biosciences Inc filed Critical Dmi Biosciences Inc
Application granted granted Critical
Publication of ATE553116T1 publication Critical patent/ATE553116T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT00967163T 1999-10-01 2000-09-29 Metall bindende verbindungen und ihre verwendungen ATE553116T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15740499P 1999-10-01 1999-10-01
US21107800P 2000-06-13 2000-06-13
PCT/US2000/026952 WO2001025265A1 (en) 1999-10-01 2000-09-29 Metal-binding compounds and uses therefor

Publications (1)

Publication Number Publication Date
ATE553116T1 true ATE553116T1 (de) 2012-04-15

Family

ID=26854102

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00967163T ATE553116T1 (de) 1999-10-01 2000-09-29 Metall bindende verbindungen und ihre verwendungen

Country Status (11)

Country Link
EP (2) EP2327713A1 (de)
JP (1) JP5349722B2 (de)
KR (6) KR101353140B1 (de)
CN (2) CN102038932B (de)
AT (1) ATE553116T1 (de)
AU (1) AU770999C (de)
BR (1) BR0014389A (de)
CA (1) CA2385551A1 (de)
IL (4) IL148797A0 (de)
NZ (1) NZ518266A (de)
WO (1) WO2001025265A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040602A1 (en) * 2001-04-30 2003-02-27 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1406 daltons
US20020160417A1 (en) * 2001-04-30 2002-10-31 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons
WO2003043518A2 (en) * 2001-11-20 2003-05-30 Dmi Biosciences, Inc. Methods and products for oral care
US7982008B2 (en) 2002-11-27 2011-07-19 David Bar-Or Treatment of diseases and conditions mediated by increased phosphorylation
US8110402B2 (en) 2008-05-13 2012-02-07 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
CN107337709B (zh) * 2017-06-29 2021-03-02 安徽省农业科学院农产品加工研究所 一种高锌螯合活性锌螯合肽及其应用
JP2024501643A (ja) * 2020-12-15 2024-01-15 ライフ テクノロジーズ コーポレーション 化学的に定義された血清アルブミン代替物
CN113563418B (zh) * 2021-06-22 2023-03-03 中国科学院化学研究所 一种原位响应ros的人工酶及其制备方法与应用
CN114437175B (zh) * 2022-01-29 2023-09-29 山东第一医科大学第三附属医院(山东省医学科学院附属医院) 一种肽探针及其应用和包含该肽探针的试剂盒

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
US4022888A (en) 1975-09-09 1977-05-10 Diagnostic Data, Inc. Esterified orgotein
US4461724A (en) 1981-10-28 1984-07-24 Nippon Zoki Pharmaceutical Co., Ltd. Peptide compounds, a process for manufacturing them, pharmaceutical compositions containing them, and methods for treating ulcer and thrombus with them
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
US4760051A (en) 1985-01-24 1988-07-26 Pickart Loren R Use of GHL-Cu as a wound-healing and anti-inflammatory agent
US4877770A (en) 1985-02-08 1989-10-31 Procyte Corporation Chemical derivatives of GHL-Cu
US5348943A (en) 1985-02-08 1994-09-20 Procyte Corporation Cosmetic and skin treatment compositions
US4767753A (en) 1985-02-08 1988-08-30 Procyte Corporation Methods and compositions for preventing ulcers
US5214032A (en) 1985-02-08 1993-05-25 Procyte Corporation GHL-CU pharmaceutical compositions and compounds
US4665054A (en) 1985-02-08 1987-05-12 Bioheal, Inc. Chemical derivatives of GHL-Cu
US5550183A (en) 1985-02-08 1996-08-27 Procyte Corporation Metal-peptide compositions and methods for stimulating hair growth
US5177061A (en) 1985-02-08 1993-01-05 Procyte Corporation Method for stimulating hair growth using GHL-Cu complexes
US5120831A (en) 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US4810693A (en) 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US5422096A (en) 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
JPS62116565A (ja) * 1985-11-15 1987-05-28 Fujisawa Pharmaceut Co Ltd 新規ペプチド
GB8603537D0 (en) 1986-02-13 1986-03-19 Parker D Conjugate compound
JP2604457B2 (ja) 1987-05-11 1997-04-30 プロサイト コーポレイション 毛の成長の刺激方法
EP0327263B1 (de) 1988-01-29 1994-09-07 PROCTOR, Peter H. Haarwachstumanregung mit Nitroxyd und anderen Radikalen
US5101041A (en) 1989-04-26 1992-03-31 The Curators Of The University Of Missouri Triamines and their derivatives as bifunctional chelating agents
US5460785A (en) 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
ATE172879T1 (de) 1989-08-09 1998-11-15 Rhomed Inc Direkte radioetikettierung von antikörpern und sonstigen proteinen mittels technetium oder rhenium
US5759515A (en) 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
US5443816A (en) 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5145838A (en) 1989-08-30 1992-09-08 Procyte Corporation Methods and compositions for healing ulcers
US5023237A (en) 1989-08-30 1991-06-11 Procyte Corporation Methods and compositions for healing ulcers
US5059588A (en) 1989-10-13 1991-10-22 Procyte Corporation, Incorporated Methods and compositions for healing bone using gly his lys: copper
US5118665A (en) 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5252559A (en) 1991-08-20 1993-10-12 The Procter & Gamble Company His-Gly-Gly peptide and derivatives thereof for hair growth
US5280038A (en) 1992-03-13 1994-01-18 Virginia Commonwealth University Histidine as a protective agent in cardiac surgery and myocardial ischemic syndrome
CA2094785A1 (en) 1992-05-08 1993-11-09 Jean Gariepy Metal chelating peptide
US5807535A (en) 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US5380747A (en) 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5650134A (en) 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
US5464934A (en) 1993-05-14 1995-11-07 Mallinckrodt Medical, Inc. Metal chelates as spacer compounds in biologically active peptides
US5994339A (en) 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
US5476939A (en) 1993-12-30 1995-12-19 Abbott Laboratories Certain pyridyl and isoquinolyl carbinolamine derivatives
JPH07316192A (ja) 1994-05-27 1995-12-05 Hoechst Japan Ltd Ｌ−リシル−グリシル−ｌ−ヒスチジンおよびこれを含有する創傷治療剤
US5538945A (en) 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes
US5891418A (en) 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
EP0955044B1 (de) 1995-06-26 2005-11-16 Chelator LLC Methode zur Hemmung des Wachstums von Bakterien oder Pilzen mit einem Komplexbildner
US5637311A (en) 1995-06-29 1997-06-10 Procyte Corporation Zinc(II) complexes and methods related thereto
RU2106146C1 (ru) 1995-07-17 1998-03-10 Институт элементоорганических соединений РАН Средство для подавления опухолевого роста
US5786335A (en) 1995-11-06 1998-07-28 Warner-Lambert Company Sulfhydryl containing peptides for treating vascular disease
US5928955A (en) 1996-03-22 1999-07-27 California Institute Of Technology Peptidyl fluorescent chemosensor for divalent zinc
WO1997044313A1 (en) 1996-05-21 1997-11-27 Novartis Ag N,N'-Di(2-HYDROXYBENZYL)ETHYLENEDIAMINE-N,N'-DIACETIC ACID DERIVATIVES
GB9613182D0 (en) 1996-06-24 1996-08-28 Nycomed Imaging As Method
PL184070B1 (pl) 1996-07-30 2002-08-30 Politechnika Lodzka Sposób wytwarzania peptydów zawierających a-hydroksymetyloserynę
US5906996A (en) 1996-08-21 1999-05-25 Murphy; Michael A. Tetramine treatment of neurological disorders
US5922761A (en) 1996-09-06 1999-07-13 Medinox, Inc. Methods for in vivo reduction of iron levels and compositions useful therefor
US5739395A (en) 1997-01-10 1998-04-14 University Of Florida Research Foundation, Inc. Method for synthesis of rhizoferrin
GB9711093D0 (en) 1997-05-29 1997-07-23 British Tech Group Novel orally active iron (III) chelators
ES2235461T3 (es) 1998-02-04 2005-07-01 University Of Florida Research Foundation, Inc. Acido n,n'-bis (2-hidroxibencil)etilendiamina-n,n'-diacetico y sales de sodio de este para terapia quelante de hierro.
DE19819843A1 (de) 1998-05-05 1999-11-11 Biotechnolog Forschung Gmbh Metallchelat bindende Peptide
US6348185B1 (en) 1998-06-20 2002-02-19 Washington University School Of Medicine Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy

Also Published As

Publication number Publication date
EP2327713A1 (de) 2011-06-01
EP1220870B1 (de) 2012-04-11
CA2385551A1 (en) 2001-04-12
IL202812A0 (en) 2011-07-31
HK1157635A1 (en) 2012-07-06
AU7740700A (en) 2001-05-10
KR20110049875A (ko) 2011-05-12
KR20120023147A (ko) 2012-03-12
NZ518266A (en) 2005-01-28
KR20090086437A (ko) 2009-08-12
WO2001025265A1 (en) 2001-04-12
KR20020057966A (ko) 2002-07-12
JP2003528814A (ja) 2003-09-30
IL207923A0 (en) 2011-07-31
EP1220870A1 (de) 2002-07-10
CN102038932B (zh) 2013-11-06
AU770999B2 (en) 2004-03-11
JP5349722B2 (ja) 2013-11-20
EP1220870A4 (de) 2004-04-07
KR20120024890A (ko) 2012-03-14
KR101353140B1 (ko) 2014-01-20
BR0014389A (pt) 2002-10-29
CN1390231A (zh) 2003-01-08
IL148797A (en) 2010-12-30
CN102038932A (zh) 2011-05-04
KR101312880B1 (ko) 2013-09-30
KR20100075503A (ko) 2010-07-02
IL148797A0 (en) 2002-09-12
AU770999C (en) 2005-04-21
KR101062041B1 (ko) 2011-09-02

Similar Documents

Publication Publication Date Title
IL207923A0 (en) Metal-binding compounds and uses therefor
ATE447574T1 (de) 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
DE60330485D1 (de) Zur behandlung von diabetes
ATE429210T1 (de) Orale flüssige zusammensetzungen
PT932402E (pt) Metodo de utilizacao de inibidores de ciclooxigenase-2 no tratamento e prevencaode neoplasia
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
EP1226109A4 (de) Phenylamin-carbonsäure-verbindungen und zubereitungen zur verabreichung von wirkstoffen
ATE417832T1 (de) Hexahydrodiazepinone als inhibitoren des dipeptidylpeptidase-iv zur behandlung bzw. prävention von diabetes
PE20050730A1 (es) Derivados de 2,5-dihidropirrol 2,2-disustituidos como inhibidores de quinesinas mitoticas
DE60320008D1 (de) Heterozyklische beta-aminoverbindungen als inhibitoren des dipeptidylpeptidase zur behandlung bzw. prevention von diabetes
ATE476985T1 (de) Von thrombozyten stammende wachstumsfaktorzusammensetzungen und anwendungsverfahren dafür
ATE373660T1 (de) Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes
ATE473742T1 (de) Kondensierte triazolderivate als dipeptidylpeptidase-iv-hemmer zur behandlung bzw. prävention von diabetes
ATE308880T1 (de) Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung
DK1041072T3 (da) Dioxocyclopentylhydroxamsyrer
ATE527261T1 (de) 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten
DE60114171D1 (de) Minoxidil enthaltende zubereitung
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
MXPA04008152A (es) Compuestos azabiciclicos para el tratamiento de enfermedades.
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
TR200606411T1 (tr) Vajinite karşı bir triazol içeren bileşimler.
MXPA03010860A (es) COMPOSICION TOPICA QUE COMPRENDE UN AGENTE DE UNION COSMeTICO SUSTITUIDO.
ATE494894T1 (de) Viruzide wirkungen von einer zubereitung enthaltend cetylpyridiniumchlorid und zitronensäure
WO2005017160A3 (en) Mobilization of hematopoietic cells
DE60013326D1 (de) Verbindungen und verfahren zur behandlung von schmerz